Adults 18 to 29, any sex, with Childhood Cancer Survivors. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Feasibility Measure: Enrollment (Young Adult Survivors) - Number of Eligible Patients Consented and Completing BaselinePrimary· Baseline
Determined by number of eligible patients consented and completing baseline. Hypothesis: \>50% of eligible will consent and complete the baseline.
Group
Value
95% CI
Randomized Control Trial Participants-Young Adult Survivors
50
Randomized Control Trial Participants-Young Adult Survivors
29
Feasibility Measure: Retention in Study (Young Adult Survivors): Percent of Consented Patients Who Are Retained in the Study and Complete Time 3 Follow-upPrimary· Time 3 at about 5 months since Baseline.
Retention in study (Young Adult Survivors). Determined by the percent of consented patients who are retained in the study and complete Time 3 follow-up. Hypothesis: \>80%.
Group
Value
95% CI
Intervention
22
Usual Care
25
Feasibility: Completion of the Intervention (Young Adult Survivors): PercentagePrimary· Time 2, about 2 months since baseline.
Mean percent completed per task: (a) On-line self-management educational modules and (b) Weekly calls with peer mentor.
On-line self-management educational modules
Group
Value
95% CI
Intervention
95.72
58.8 – 100
Weekly calls with peer mentor
Group
Value
95% CI
Intervention
97.72
66.7 – 100
Feasibility: Satisfaction With Intervention (Young Adult Survivors): MeanPrimary· Time 2, about 2 months since baseline.
Five items assess satisfaction with each aspect of the intervention: a. Overall program satisfaction; b. Content of online modules; c. Discussions with peer mentor; d. Frequency of calls with peer mentor; and e. Duration of program. First 3 items (a, b and c) were evaluated using a 5-point scale, (Minimum 1, Maximum 5) with higher scores indicating greater satisfaction. Item c evaluated on a scale from 1 "not frequent enough" to 3 "too frequent". Item d uses a 1 "way too short" to 5 "way too long" scale. The sample mean will be examined.
a. Satisfaction w/ Program overall [Scale 1-5]
Group
Value
95% CI
Intervention
4.64
± 0.49
b. Satisfaction w/ Content of online modules [Scale 1-5]
Group
Value
95% CI
Intervention
4.41
± 0.59
c. Satisfaction w/ Discussions with peer mentor [Scale 1-5]
Group
Value
95% CI
Intervention
4.64
± 0.49
d. Satisfaction w/ Frequency of calls with peer mentor [Scale 1-3; 2="Just right"]
Group
Value
95% CI
Intervention
2.00
± 0.31
e. Satisfaction w/ Duration of program [Scale 1-5; 3= "Just right"
Group
Value
95% CI
Intervention
2.86
± 0.47
Feasibility: Utility of the Online Self-Management Modules (Young Adult Survivors): QuestionnairePrimary· Time 2, about 2 months since baseline.
The Utility Questionnaire is an 11-item scale that measures perceived ease of use and convenience of the online program using a 5-point scale, (minimum 1, maximum 5) with higher scores indicating greater perceived utility. An overall mean of all items will be calculated.
Group
Value
95% CI
Intervention
4.35
± 0.54
Feasibility: Impact of the Online Self-Management Modules (Young Adult Survivors): QuestionnairePrimary· Time 2, about 2 months since baseline.
The Impact Questionnaire is a 13-item scale that measures perceived effectiveness of the online program using a 5-point scale, (minimum 1, and maximum 5) with higher scores indicating greater perceived effectiveness. An overall mean of all items will be calculated.
Group
Value
95% CI
Intervention
4.29
± 0.48
Feasibility: Adherence Barriers to the Online Self-Management Modules (Young Adult Survivors): QuestionnairePrimary· Time 2, about 2 months since baseline.
The Adherence Barriers Questionnaire is a 6-item scale that measures perceived barriers to using the online program using a 5-point scale, (minimum 1 and maximum 5) with higher scores indicating greater perceived barriers. An overall mean of all items will be calculated.
Group
Value
95% CI
Intervention
1.17
± 0.24
Acceptance of Peer Mentors (Young Adult Survivors and Peer Mentors): QuestionnairePrimary· Time 2, about 2 months since baseline
Acceptance will be evaluated by young adult survivors' and peer mentors' report on perceived alliance with each other using the Working Alliance Inventory - Short Form Revised (Hatcher \& Gillaspy, 2006), a validated measure of the quality and strength of the relationship. Items are rated on a 5-point scale. The measure yields 3 subscales summary scores that can range from 5 to 20, with higher scores indicating more positive relationships. Sum scores on each sub-scale with be calculated: Bond, Goal, and Task.
Bond
Group
Value
95% CI
Intervention
18.41
± 1.92
Mentors
19.55
± 1.14
Goal
Group
Value
95% CI
Intervention
17.68
± 2.28
Mentors
13.45
± 1.71
Task
Group
Value
95% CI
Intervention
18.14
± 2.01
Mentors
13.09
± 1.66
Healthcare Responsibility (Young Adult Survivors)Secondary· Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).
The Readiness for Transition Questionnaire - Survivor Version (RTQ) assesses the degree to which survivors are responsible for 10 healthcare behaviors, including knowing their survivorship care plan, scheduling annual visits, scheduling specialist appointments, taking and filling medications (if prescribed), explaining medical history to others, knowing insurance coverage, attending appointments, communicating with providers, and calling providers, on a 4-point scale, with higher scores indicating higher levels of responsibility. The RTQ yields a total mean score for responsibility. It also ha
Baseline RTQ Total
Group
Value
95% CI
Intervention
2.73
± 0.63
Usual Care
2.83
± 0.54
Time 2 RTQ Total
Group
Value
95% CI
Intervention
3.1
± 0.67
Usual Care
3.08
± 0.49
Time 3 RTQ Total
Group
Value
95% CI
Intervention
3.02
± 0.72
Usual Care
3.07
± 0.64
Time 4 RTQ Total
Group
Value
95% CI
Intervention
3.16
± 0.64
Usual Care
3.23
± 0.63
Baseline RTQ Overall readiness
Group
Value
95% CI
Intervention
2.36
± 0.76
Usual Care
2.8
± 0.96
Time 2 RTQ Overall readiness
Group
Value
95% CI
Intervention
2.64
± 0.85
Usual Care
2.76
± 0.97
Time 3 RTQ Overall readiness
Group
Value
95% CI
Intervention
2.86
± 0.77
Usual Care
2.8
± 0.91
Time 4 RTQ Overall readiness
Group
Value
95% CI
Intervention
3.14
± 0.79
Usual Care
3.04
± 0.95
Knowledge (Young Adult Survivors)Secondary· Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline)
The knowledge subscale from the Transition Readiness Inventory (TRI) measures knowledge of survivorship care using a 5-point scale, with higher scores indicating greater knowledge. A mean score will be calculated (range 1-5).
Baseline
Group
Value
95% CI
Intervention
3.44
± 0.71
Usual Care
3.9
± 0.76
Time 2
Group
Value
95% CI
Intervention
4.1
± 0.67
Usual Care
4.13
± 0.68
Time 3
Group
Value
95% CI
Intervention
4.4
± 0.7
Usual Care
4.45
± 0.77
Self-Management Skills/Self-Efficacy (Young Adult Survivors)Secondary· Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline)
The Skills/Self-Efficacy sub-scale from the Transition Readiness Inventory (TRI) measures self-management skills and self-efficacy for survivorship care using a 5-point scale, with higher scores indicating greater skills/efficacy. A mean score will be calculated (range 1-5).
Baseline
Group
Value
95% CI
Intervention
3.4
± 0.68
Usual Care
3.81
± 0.71
Time 2
Group
Value
95% CI
Intervention
3.72
± 0.78
Usual Care
3.92
± 0.66
Time 3
Group
Value
95% CI
Intervention
3.84
± 0.76
Usual Care
4.00
± 0.77
Self-Management Goals (Young Adult Survivors)Secondary· Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline)
The Goals subscale from the Transition Readiness Inventory (TRI) measures self-management goals for survivorship care using a 5-point scale, with higher scores indicating greater goals. A mean score will be calculated (range 1-5).
Baseline
Group
Value
95% CI
Intervention
3.44
± 0.91
Usual Care
3.99
± 1
Time 2
Group
Value
95% CI
Intervention
4.10
± 0.71
Usual Care
4.30
± 0.72
Time 3
Group
Value
95% CI
Intervention
4.06
± 0.67
Usual Care
4.30
± 0.89
Sponsor's own description
The goal of this project is to evaluate the feasibility of the "Managing Your Health" online self-management skills+peer mentoring intervention that focuses on overcoming survivor barriers to self-management of their survivorship care. We will conduct a pilot randomized controlled trial (RCT) of the intervention versus usual care with adolescent and young adult survivors of childhood cancer ages 18-25 years. Participants will complete survey measures at baseline, Time 2 (about 2 months after baseline), Time 3 (about 5 months after baseline), and Time 4 (about 12 months after baseline).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Other recruiting trials for Childhood Cancer Survivors
Currently open trials in the same condition.
NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial
· NA
· active not recruiting
NCT07398677 — SchoolCare: A Social Intervention Introducing Telepresence Robots and School Navigation to Reduce School Fragmentation f
· NA
· recruiting
NCT06872840 — Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility
· NA
· recruiting
NCT07009288 — A Study of Time-Restricted Eating in Childhood Cancer Survivors
· NA
· recruiting
NCT06609473 — Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Surviv
· NA
· recruiting
Other Rutgers, The State University of New Jersey trials
Trials by the same sponsor.
NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD)
· NA
· not yet recruiting
NCT06955130 — Lactate and Glycerol Contribution to Gluconeogenesis
· NA
· not yet recruiting
NCT06822010 — SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
· Phase 2
· not yet recruiting
NCT07525011 — Comparative Study of Denture Fabrication Techniques
· NA
· not yet recruiting
NCT06834204 — Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rutgers, The State University of New Jersey
Last refreshed: 31 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04075734.